Search hospitals > Missouri > Columbia
University of Missouri
Claim this profileColumbia, Missouri 65201
Global Leader in Obesity
Global Leader in Diabetes
Conducts research for Unintentional Home Injuries
Conducts research for Coronavirus
Conducts research for Hip Fracture
301 reported clinical trials
30 medical researchers
Summary
University of Missouri is a medical facility located in Columbia, Missouri. This center is recognized for care of Obesity, Diabetes, Unintentional Home Injuries, Coronavirus, Hip Fracture and other specialties. University of Missouri is involved with conducting 301 clinical trials across 528 conditions. There are 30 research doctors associated with this hospital, such as Puja Nistala, Christos Papageorgiou, Katie Murray, DO, MS, SACS, and Dima Dandachi, MD.Top PIs
Puja NistalaUniversity of Missouri - Ellis Fischel3 years of reported clinical research
Studies Skin Cancer
Studies Breast Cancer
26 reported clinical trials
86 drugs studied
Christos PapageorgiouMU Health - University Hospital/Ellis Fischel Cancer Center1 year of reported clinical research
Studies Breast Cancer
Studies Breast cancer
10 reported clinical trials
26 drugs studied
Katie Murray, DO, MS, SACSUniversity of Missouri - Ellis Fischel3 years of reported clinical research
Studies Bladder Cancer
Studies Transitional Cell Carcinoma
8 reported clinical trials
23 drugs studied
Dima Dandachi, MDGSK Investigational Site1 year of reported clinical research
Studies Human Immunodeficiency Virus Infection
Studies Antiretroviral Therapy
6 reported clinical trials
9 drugs studied
Clinical Trials running at University of Missouri
Breast Cancer
Insomnia
Skin and Soft Tissue Infections
Infections and Infestations
Dementia
Abdominal Aortic Aneurysm
Kidney Failure
Vasodilation
Aging
Ascending Aortic Aneurysm
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
Giredestrant + Hormone Therapy
for Early-Stage Breast Cancer
This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Recruiting2 awards Phase 311 criteria
Cognitive Rehabilitation
for Breast Cancer Survivors
The goal of this proposed project is to evaluate the feasibility and preliminary effect of metacognitive strategy training to improve activity performance, cognition, and quality of life in breast cancer survivors with cancer-related cognitive impairment (CRCI). The other goal of this proposed project is to examine the effects of CO-OP on resting (rsFC)- and task-state functional connectivity as compared to an inactive control group.
Recruiting1 award N/A1 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Missouri?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.